Skip to main content

Table 1 Demographic data

From: Safety and efficacy of percutaneous patent ductus arteriosus closure: a multicenter Egyptian experience

Age

Median = 2.7 years (range 3 months–20 years)

Gender

Males, n = 113 (36.7%), females, n = 195 (63.3%)

Weight

Median = 11.8 kgs (range 5–90 kgs)

Size of PDA by angiography

Median = 2.86 ± 0.96 mm (range 1.5–7.6 mm)

Mean PAP

Median 15.5 mmHg (range 10–55 mmHg)

QP: Qs

Median 2.15 ± 0.8 (1–3.5)

Procedural time

Mean 53 ± 6.8 min (range 42–70 min)

Fluoroscopy time

Mean 6.8 ± 0.86 min (range 6–9 min)

Type of intervention

Device closure, n = 208 (67.5%), coil closure n = 100 (32.5%)

Type of PDA

Type A n = 250 (81%), type C, n = 48 (15.5%), type B, n = 8 (2.5%), type D, n = 2 (0.6%)

Device type

ADO I n = 132 (42.8%), Hyperion n = 25 (8.1%), Occlutech n = 24 (7.8%)

Lifetech n = 12 (3.8%). Amplatzer Muscular VSD, n = 10 (3.2%), ADO II, n = 4 (1.29%)

Device size

Median 6 mm (range from 6 to 12 mm)

Complications

n = 15 (5%)

  1. PDA patent ductus arteriosus, PAP pulmonary artery pressure, VSD ventricular septal defect